AstraZeneca has signed a deal worth up to $5.2bn to work with a Chinese biotech company using AI to develop new treatments for chronic diseases.

The Company's common stock is expected to begin trading on a split-adjusted basis when the markets open on Tuesday, June 17, 2025 under the Company's existing trading symbol "SNSE" with the new CUSIP ...

The Sahara Desert, known for its vast, arid landscape and scorching temperatures, has long been a place of mystery. However, recent discoveries beneath its scorching sands have shocked the world. A ...

Virgin Island received backlash from viewers for the show's 'exploitative' premise, which involved encouraging adult virgins to embrace their sexuality for the first time on TV ...